Category: News

The AACR Cancer Disparities Progress Report 2026 included an examination of the growing gap in cancer care between rural and urban areas. The report also featured the stories of several cancer survivors—including Dennis Gruenhagen, Melanie R. Stewart, and Sebastián Casaus Natale—whose care was impacted by geographical barriers.

The post The Long Road to Receiving Care—Examining Cancer Disparities in Rural Areas  appeared first on American Association for Cancer Research (AACR).

The cochairs of the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers—Andrew Futreal, PhD, FAACR, of The University of Texas MD Anderson Cancer Center; Taran Gujral, PhD, of Fred Hutch Cancer Center; Brooke E. Howitt, MD, of Stanford University; and Patrick Tan, MD, PhD, of Duke-NUS Medical School in Singapore—shared updates about the current status of rare cancer research and what excites them most about this upcoming meeting.

The post Uncommon Cancers, Common Goals: Overcoming the Challenges of Rare Cancer Research appeared first on American Association for Cancer Research (AACR).

Can AI agents do cancer research? Many AI-centric research teams currently believe that with the right training, AI agents can in fact rise to the level of “co-scientists,” including Jure Leskovec, PhD, of Stanford University, who spoke about designing one of the first generalist biomedical research agents at the AACR Annual Meeting 2026.

The post Eye on AI: Agentic AI Brings Bots to the Bench appeared first on American Association for Cancer Research (AACR).

Chenia Lloyd-Gascho, who was diagnosed with Li-Fraumeni syndrome when he was 8 years old, shared what it is like to grow up knowing you will one day get cancer, the routine monitoring recommended to try to catch cancer early, what happens once you are diagnosed with cancer, and the psychological toll that all this can take on you.

The post What Does It Mean to Be Diagnosed With Li-Fraumeni Syndrome? appeared first on American Association for Cancer Research (AACR).

Melanoma expert Ashani T. Weeraratna, PhD, of Johns Hopkins Bloomberg School of Public Health, explains how bemotrizinol—the first new sunscreen ingredient to be approved by the FDA in over 25 years—compares with currently used ingredients. Weeraratna breaks down how bemotrizinol works, its safety profile, its effectiveness, and more.

The post What to Know About the New FDA-approved Sunscreen Ingredient Bemotrizinol appeared first on American Association for Cancer Research (AACR).

At the AACR Annual Meeting 2026, we conducted “Bite-sized Research” interviews with attendees for morsels of knowledge about their work, including Brian G. Morreale, PhD, of the University at Buffalo; Prashanth Gokare, PhD, of Johnson & Johnson, Amulya Sreekumar, PhD, of the University of Pennsylvania; and Long Chi Nguyen, PhD, MD, and Eva Suarez, of the University of Chicago.

The post AACR Annual Meeting 2026: Bite-sized Research appeared first on American Association for Cancer Research (AACR).

Researchers are building AI agents to assess how patients could respond to therapy and aid doctors in making cancer treatment decisions.

The post Eye on AI: AI Agents as Doctors’ Deputies in the Cancer Clinic appeared first on American Association for Cancer Research (AACR).

At the AACR Annual Meeting 2026, Lillian Siu shared her research into cancer interception and assembled a panel to discuss targeted cancer prevention.

The post AACR Annual Meeting 2026 Presidential Sessions Explore Cancer Interception and Prevention appeared first on American Association for Cancer Research (AACR).

At the AACR Annual Meeting 2026, researchers discussed the use of vaccines and aspirin to prevent cancer in people with Lynch syndrome.

The post Stopping Cancer Before It Starts in Lynch Syndrome appeared first on American Association for Cancer Research (AACR).

The inaugural AACR Drug Discovery and Development (AACR D3) meeting will convene experts to reshape the future of oncology therapeutics.

The post AACR D3: The ‘Global One-stop Conference’ for Drug Discovery and Development appeared first on American Association for Cancer Research (AACR).